NASDAQ:ICAD

Delisted

Icad Stock News

Healthcare > Medical - Devices

Buy ICAD

*Your capital is at risk

$3.87

+0 (+0%)

At Close: Oct 16, 2025

iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

01:00pm, Tuesday, 26'th Nov 2024

ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025 ProFound Health, a Virtual Care Partnership with

iCAD, Inc. (ICAD) Q3 2024 Earnings Call Transcript

06:53pm, Wednesday, 13'th Nov 2024

iCAD, Inc. (NASDAQ:ICAD ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Rosalyn Christian - Investor Relations Dana Brown - President, Chief Executive Officer and

iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

04:01pm, Wednesday, 13'th Nov 2024

NASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically prove

iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

08:00am, Wednesday, 06'th Nov 2024

NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can't hide by providing clinical

iCAD to Participate in the LD Micro Main Event XVII

08:00am, Wednesday, 16'th Oct 2024

Nashua, New Hampshire--(Newsfile Corp. - October 16, 2024) - iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing cli

iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024

08:00am, Thursday, 03'rd Oct 2024

NASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, today

iCAD, Inc. (ICAD) Q2 2024 Earnings Call Transcript

09:05pm, Tuesday, 13'th Aug 2024

iCAD, Inc. (NASDAQ:ICAD ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Rosalyn Christian - Investor Relations Dana Brown - President, Chief Executive Officer and Ch

iCAD Reports Financial Results for Second Quarter Ended June 30, 2024

04:01pm, Tuesday, 13'th Aug 2024

NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can't hide by providing clinical

iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography

08:00am, Monday, 29'th Jul 2024

Windsong Radiology to Champion First Wave of ProFound AI Breast Health Suite Expansion Windsong Radiology to Champion First Wave of ProFound AI Breast Health Suite Expansion

iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024

08:00am, Wednesday, 26'th Jun 2024

Newly Launched ProFound Cloud Delivers Radiologists Cost-Effective, Secure, and Scalable Access to iCAD's Breast Health Suite of AI Solutions Newly Launched ProFound Cloud Delivers Radiologists Cost-E

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by